CAITLIN HAGEDORN: Open Payments
NPI 1285240226 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 19 payments from 13 companies in 2025. Trend: 2023 $777 · 2024 $86 · 2025 $1,091
Food & beverage: $505Travel & lodging: $503Education: $83
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $610 |
| SEAGEN INC. | 1 | $83 |
| Geron Corporation | 1 | $80 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| SOBI, INC | 2 | $38 |
| PFIZER INC. | 2 | $36 |
| Eisai Inc. | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $33 |
| SERVIER PHARMACEUTICALS LLC | 1 | $24 |
Products named: RYTELO, LUTATHERA, LYNOZYFIC, Vonjo, ELREXFIO, Lenvima, CARVYKTI, Oncaspar.
Industry payments across AL — which companies pay providers there.
